BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18285405)

  • 1. Lovastatin inhibits formation of AA amyloid.
    van der Hilst JC; Kluve-Beckerman B; Bodar EJ; van der Meer JW; Drenth JP; Simon A
    J Leukoc Biol; 2008 May; 83(5):1295-9. PubMed ID: 18285405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome.
    Frenkel J; Rijkers GT; Mandey SH; Buurman SW; Houten SM; Wanders RJ; Waterham HR; Kuis W
    Arthritis Rheum; 2002 Oct; 46(10):2794-803. PubMed ID: 12384940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
    Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
    J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AA amyloidosis complicating the hereditary periodic fever syndromes.
    Lane T; Loeffler JM; Rowczenio DM; Gilbertson JA; Bybee A; Russell TL; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
    Arthritis Rheum; 2013 Apr; 65(4):1116-21. PubMed ID: 23280696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model.
    Magy N; Benson MD; Liepnieks JJ; Kluve-Beckerman B
    Amyloid; 2007 Mar; 14(1):51-63. PubMed ID: 17453625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brefeldin A inhibits experimentally induced AA amyloidosis.
    Stenstad T; Husby G
    J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose lovastatin decreased basal prostacyclin production in cultured endothelial cells.
    Zhou Q; Zhou Y; Kummerow FA
    Prostaglandins Other Lipid Mediat; 2009 Jun; 89(1-2):1-7. PubMed ID: 19135546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome.
    van der Hilst JC; Drenth JP; Bodar EJ; Bijzet J; van der Meer JW; Simon A;
    Amyloid; 2005 Jun; 12(2):115-9. PubMed ID: 16011988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
    Simon A; Drewe E; van der Meer JW; Powell RJ; Kelley RI; Stalenhoef AF; Drenth JP
    Clin Pharmacol Ther; 2004 May; 75(5):476-83. PubMed ID: 15116060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response.
    Verine J; Mourad N; Desseaux K; Vanhille P; Noël LH; Beaufils H; Grateau G; Janin A; Droz D
    Hum Pathol; 2007 Dec; 38(12):1798-809. PubMed ID: 17714761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study.
    Inoue S; Hultin PG; Szarek WA; Kisilevsky R
    Lab Invest; 1996 Jun; 74(6):1081-90. PubMed ID: 8667612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic AA amyloidosis induced by benign neoplasms].
    Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
    Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism.
    Lundmark K; Westermark GT; Olsén A; Westermark P
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6098-102. PubMed ID: 15829582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mevalonate synthesis pathway as a therapeutic target in cancer.
    Andela VB; Pirri M; Schwarz EM; Puzas EJ; O'Keefe RJ; Rosenblatt JD; Rosier RN
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S59-66. PubMed ID: 14600593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amyloidosis AA].
    Stankovic K; Grateau G
    Nephrol Ther; 2008 Jul; 4(4):281-7. PubMed ID: 18514052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental AA amyloidosis in mice is inhibited by treatment with triptolide, a purified traditional Chinese medicine.
    Cui D; Hoshii Y; Kawano H; Sugiyama S; Gondo T; Liu Y; Ishihara T
    Int Immunopharmacol; 2007 Sep; 7(9):1232-40. PubMed ID: 17630202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antioxidant effect of lovastatin on phagocyte-induced DNA damage: implications for cancer prevention.
    Weitberg AB
    J Exp Clin Cancer Res; 2007 Dec; 26(4):583-6. PubMed ID: 18365556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.